Increased intakes of long-chain menaquinones (vitamin K2) may reduce the risk of mortality from coronary heart disease (CHD), according to data from the European Prospective Investigation into Cancer and Nutrition (EPIC-NL) cohort.
from NutraIngredients RSS http://ift.tt/2cHoNUI
via IFTTT